Replay available

Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call

Medpace Holdings, Inc. (NASDAQ: MEDP) Q4 2023 earnings conference call, held 2024-02-13. Replay captured from the company's public earnings webcast.

Tue, February 13, 2024 at 9:00 AMendedReplay
Medpace Holdings, Inc. (MEDP) Q4 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Lauren Morris

Director of Investor Relations

Jesse Geiger

President

Kevin Brady

CFO

August Trendle

CEO

David Windley

Jefferies Analyst

Max Smock

William Blair Analyst

Jack Wallace

Guggenheim Partners Analyst

Eric Coldwell

Baird Analyst

Replay transcript excerpt

Good day, ladies and gentlemen, and welcome to the MedPace fourth quarter and full year 2023 earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question and answer session, and instructions will follow at that time. As a reminder, this call may be recorded. I would now like to introduce your host for today's conference call, Lauren Morris, MedPace's Director of Investor Relations. You may begin. Good morning, and thank you for joining MedPace's fourth quarter and full year 2023 earnings conference call. Also on the call today is our CEO, August Trendle, our President, Jesse Geiger, and our CFO, Kevin Brady. Before we begin, I would like to remind you that our remarks and responses to your questions during this teleconference may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve inherent assumptions with known and unknown risks and uncertainties as well as other important factors that could cause actual results to differ materially from our current expectations. These factors are discussed in our Form 10-K and other filings with the SEC. Please note that we assume no obligation to update forward-looking statements even if estimates change. Accordingly, you should not rely on any of today's forward-looking statements as representing our reviews as of any date after today. During this call, we will also be referring to certain non-GAAP financial measures. These non-GAAP measures are not superior to or a replacement for the comparable GAAP measures, but we believe these measures help investors gain a more complete understanding of results. A reconciliation of such non-GAAP financial measures to the most directly comparable GAAP m...

More from Medpace Holdings, Inc.